Antivirus Therapeutics

Antivirus Therapeutics is a biotechnology company focused on the development of broad-spectrum antiviral medications to combat emerging and seasonal viral threats. The company utilizes a proprietary discovery platform to identify small molecule candidates that target highly conserved viral mechanisms, such as polymerase and protease functions, across multiple virus families. Their primary goal is to create "one-drug-multiple-virus" solutions that can be deployed rapidly during outbreaks. Currently, the company is advancing several lead candidates through pre-clinical validation for indications including influenza and coronaviruses.